| Inotropic support group(n = 50) | Noninotropic support group(n = 47) | P value |
---|---|---|---|
Age (≥ 70 years) | 31 (32%) | 18 (19%) | 0.02 |
Sex | Â | Â | Â |
   Male | 24(25%) | 19(20%) | 0.43 |
   Women | 26(27%) | 28(29%) |  |
BMI ≥ 30 | 28(29%) | 14(14%) | 0.04 |
Diabetes Mellitus | 21(22%) | 25(26%) | 0.61 |
CKD stage 3–5 (GFR<60 mL/min/1.73 m2) | 14(14%) | 5(5%) | 0.02 |
Pulmonary hypertension | 18(19%) | 15(15%) | 0.69 |
LVEF ≤ 40% | 45(46%) | 31(32%) | 0.001 |
LVH | 36(37%) | 43(44%) | 0.11 |
Moderate to severe MR | 21(22%) | 15(15%) | 0.37 |
Wall motion abnormalities | 16(16%) | 14(14%) | 0.86 |
Drop of hemoglobin ≥ 6 gm/dl | 29(30%) | 16(16%) | 0.02 |
Pre-operative use of beta blocker | 26(27%) | 31(32%) | 0.23 |
LVEDP ≥ 20 mm Hg | 45(46%) | 31(32%) | 0.006 |
CI ≤ 2.5 L/min/m2 | 29(30%) | 15(15%) | 0.001 |